Published in Mech Dev on January 08, 2005
Eyes absent 1 (Eya1) is a critical coordinator of epithelial, mesenchymal and vascular morphogenesis in the mammalian lung. Dev Biol (2010) 1.59
The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear. Development (2010) 1.24
Connecting the ear to the brain: Molecular mechanisms of auditory circuit assembly. Prog Neurobiol (2011) 1.23
Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Hum Mol Genet (2006) 1.13
Eya1 and Six1 promote neurogenesis in the cranial placodes in a SoxB1-dependent fashion. Dev Biol (2008) 1.12
Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear. Dev Biol (2006) 1.10
Canonical Wnt signaling modulates Tbx1, Eya1, and Six1 expression, restricting neurogenesis in the otic vesicle. Dev Dyn (2010) 0.90
Six1 transcription factor is critical for coordination of epithelial, mesenchymal and vascular morphogenesis in the mammalian lung. Dev Biol (2011) 0.89
EYA1 mutations associated with the branchio-oto-renal syndrome result in defective otic development in Xenopus laevis. Biol Cell (2010) 0.84
Segregating neural and mechanosensory fates in the developing ear: patterning, signaling, and transcriptional control. Cell Tissue Res (2014) 0.83
An in vitro model of developmental synaptogenesis using cocultures of human neural progenitors and cochlear explants. Stem Cells Dev (2012) 0.81
Challenges for stem cells to functionally repair the damaged auditory nerve. Expert Opin Biol Ther (2012) 0.79
Directing human induced pluripotent stem cells into a neurosensory lineage for auditory neuron replacement. Biores Open Access (2014) 0.78
The role of the hindbrain in patterning of the otocyst. Dev Biol (2007) 0.77
Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol (2004) 2.74
Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. Anal Chem (2006) 2.32
Tissue elongation requires oscillating contractions of a basal actomyosin network. Nat Cell Biol (2010) 2.15
The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol (2011) 2.10
Sertoli cells from non-obstructive azoospermia and obstructive azoospermia patients show distinct morphology, Raman spectrum and biochemical phenotype. Hum Reprod (2013) 2.06
Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest (2006) 2.05
Artificial selection for determinate growth habit in soybean. Proc Natl Acad Sci U S A (2010) 2.02
Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks, China. Emerg Infect Dis (2011) 1.82
A natural allele of Nxf1 suppresses retrovirus insertional mutations. Nat Genet (2003) 1.67
Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev Technol (2006) 1.64
Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus. J Immunol (2004) 1.53
Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays. J Biomol Screen (2005) 1.52
GRM7 variants confer susceptibility to age-related hearing impairment. Hum Mol Genet (2008) 1.49
Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects. Chem Biol (2009) 1.47
Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J Clin Microbiol (2010) 1.45
The application of cell-based label-free technology in drug discovery. Biotechnol J (2008) 1.41
Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation. J Atheroscler Thromb (2015) 1.38
RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol (2005) 1.32
Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res (2007) 1.31
Rab11 regulates cell-cell communication during collective cell movements. Nat Cell Biol (2013) 1.19
Spatiotemporal control of small GTPases with light using the LOV domain. Methods Enzymol (2011) 1.18
Identification of microRNAs from different tissues of chicken embryo and adult chicken. FEBS Lett (2006) 1.18
Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock. J Biol Chem (2011) 1.17
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment. Br J Pharmacol (2012) 1.17
Immune cell recruitment following acoustic trauma. Hear Res (2006) 1.17
Live cell quality control and utility of real-time cell electronic sensing for assay development. Assay Drug Dev Technol (2006) 1.12
Ion-channel assay technologies: quo vadis? Drug Discov Today (2001) 1.12
Cu/Zn superoxide dismutase and age-related hearing loss. Hear Res (2005) 1.11
Feedback inhibition of Jak/STAT signaling by apontic is required to limit an invasive cell population. Dev Cell (2008) 1.11
Dynamic and label-free monitoring of natural killer cell cytotoxic activity using electronic cell sensor arrays. J Immunol Methods (2006) 1.08
Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl (2002) 1.08
Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol (2003) 1.07
Label-free, real-time monitoring of IgE-mediated mast cell activation on microelectronic cell sensor arrays. J Immunol Methods (2004) 1.07
Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope (2002) 1.06
Roles of iron acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin and aerobactin contribute more to virulence than heme in a chicken infection model. BMC Microbiol (2012) 1.06
OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol (2011) 1.05
Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System. J Lab Autom (2011) 1.04
Synthesis and anti-tumor evaluation of new trisulfide derivatives. Bioorg Med Chem Lett (2006) 1.03
Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid Redox Signal (2003) 1.02
Innate immunity contributes to cochlear adaptive immune responses. Audiol Neurootol (2004) 1.00
Characterization of duck H5N1 influenza viruses with differing pathogenicity in mallard (Anas platyrhynchos) ducks. Avian Pathol (2009) 0.98
Label-free and real-time cell-based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array. J Biomol Screen (2006) 0.98
Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol Neurootol (2009) 0.98
Shining light on Drosophila oogenesis: live imaging of egg development. Curr Opin Genet Dev (2011) 0.98
Orthopaedic injury analysis in the 2010 Yushu, China earthquake. Injury (2011) 0.96
Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections. J Infect Dis (2013) 0.96
Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development. Circ Res (2014) 0.94
Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res (2012) 0.94
Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE). Ann N Y Acad Sci (2003) 0.94
Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol (2009) 0.94
Effects of antioxidants on the aging inner ear. Hear Res (2006) 0.93
Modulation of myocardin function by the ubiquitin E3 ligase UBR5. J Biol Chem (2010) 0.93
Tumor necrosis factor alpha can induce recruitment of inflammatory cells to the cochlea. Otol Neurotol (2008) 0.93
Gold-ionic liquid nanofluids with preferably tribological properties and thermal conductivity. Nanoscale Res Lett (2011) 0.92
CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice. Autoimmunity (2004) 0.92
Border cell migration: a model system for live imaging and genetic analysis of collective cell movement. Methods Mol Biol (2011) 0.90
Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool. J Clin Microbiol (2014) 0.89
Underwater superoleophobic graphene oxide coated meshes for the separation of oil and water. Chem Commun (Camb) (2014) 0.89
Blockage of immune-mediated inner ear damage by etanercept. Otol Neurotol (2003) 0.88
Rapid and quantitative assessment of cell quality, identity, and functionality for cell-based assays using real-time cellular analysis. J Biomol Screen (2011) 0.88
A benchmark study with sealchip planar patch-clamp technology. Assay Drug Dev Technol (2003) 0.88
Screening and identification of small molecule compounds perturbing mitosis using time-dependent cellular response profiles. Anal Chem (2010) 0.88
shRNA transcribed by RNA Pol II promoter induce RNA interference in mammalian cell. Mol Biol Rep (2006) 0.88
CMRF-35-like molecule 3 preferentially promotes TLR9-triggered proinflammatory cytokine production in macrophages by enhancing TNF receptor-associated factor 6 ubiquitination. J Immunol (2011) 0.88
AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis. Laryngoscope (2007) 0.86
Acoustic trauma augments the cochlear immune response to antigen. Laryngoscope (2008) 0.86
Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamics. Mol Cancer Ther (2009) 0.85
Transforming growth factor beta expression during an inner ear immune response. Ann Otol Rhinol Laryngol (2006) 0.85
Apoptin enhances the oncolytic properties of Newcastle disease virus. Intervirology (2011) 0.85
SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation. Biochem Biophys Res Commun (2012) 0.85
Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology. J Virol Methods (2011) 0.84
Combination of fluorescence color and melting temperature as a two-dimensional label for homogeneous multiplex PCR detection. Nucleic Acids Res (2013) 0.84
The transcription factor TEAD1 represses smooth muscle-specific gene expression by abolishing myocardin function. J Biol Chem (2013) 0.83
Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Biochem Biophys Res Commun (2009) 0.83
Single molecules reorientation reveals the dynamics of polymer glasses surface. Phys Chem Chem Phys (2009) 0.83
A simple route to synthesize size-controlled Ag(2)S core-shell nanocrystals, and their self-assembly. Nanotechnology (2008) 0.82
Lack of detection of host associated differences in Newcastle disease viruses of genotype VIId isolated from chickens and geese. Virol J (2012) 0.82
Study on the formation and depolymerization of acridine orange dimer in acridine orange-sodium dodecyl benzene sulfonate-protein system. J Colloid Interface Sci (2006) 0.82
Advanced technologies for genomic analysis in farm animals and its application for QTL mapping. Genetica (2008) 0.82
Repression of smooth muscle differentiation by a novel high mobility group box-containing protein, HMG2L1. J Biol Chem (2010) 0.82
Inflammatory signals increase Fas ligand expression by inner ear cells. J Neuroimmunol (2002) 0.82
Light activated cell migration in synthetic extracellular matrices. Biomaterials (2012) 0.81
Induction of MHC class II antigens on cells of the inner ear. Audiol Neurootol (2002) 0.81
Single-molecule interfacial electron transfer dynamics manipulated by an external electric current. Phys Chem Chem Phys (2011) 0.81
Kinetic cellular phenotypic profiling: prediction, identification, and analysis of bioactive natural products. Anal Chem (2011) 0.81
Prevalence and drug resistance of nontuberculous mycobacteria, northern China, 2008-2011. Emerg Infect Dis (2014) 0.81
Organic vapor sensing based on the light scattering effect of condensed microdroplets. Small (2012) 0.80
RfaH promotes the ability of the avian pathogenic Escherichia coli O2 strain E058 to cause avian colibacillosis. J Bacteriol (2013) 0.80
MicroRNA-27a activity is not suppressed in porcine oocytes. Front Biosci (Elite Ed) (2012) 0.80
Dissection of the genetic architecture underlying the plant density response by mapping plant height-related traits in maize (Zea mays L.). Mol Genet Genomics (2015) 0.80
Identification of two major loci that suppress hearing loss and cochlear dysmorphogenesis in Eya1bor/bor mice. Genomics (2006) 0.80
B-Myb represses elastin gene expression in aortic smooth muscle cells. J Biol Chem (2004) 0.79
Pathogenicity and immunogenicity of a mutant strain of Listeria monocytogenes in the chicken infection model. Clin Vaccine Immunol (2011) 0.79
Simultaneous detection of trisomies 13, 18, and 21 with multiplex ligation-dependent probe amplification-based real-time PCR. Clin Chem (2010) 0.79
Characterization of Edwardsiella tarda rpoN: roles in σ(70) family regulation, growth, stress adaption and virulence toward fish. Arch Microbiol (2012) 0.79
Mapping of genetic modifiers of Eya1 ( bor/bor ) in CAST/EiJ and BALB/cJ that suppress cochlear aplasia and associated deafness. Mamm Genome (2008) 0.78
Immunological damage to the inner ear: current and future therapeutic strategies. Adv Otorhinolaryngol (2002) 0.78
A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing. Adv Healthc Mater (2013) 0.78